Who Owns DBV Technologies S.A. Stock?
NASDAQ: DBVTHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 41.66%
- Held by insiders
- 0.00%
- Institutional holders
- 87
- Institutions 41.7%
- Insiders 0.0%
- Public and other 58.3%
Who owns DBV Technologies S.A. stock?
Institutional investors own about 41.7% of DBV Technologies S.A.'s shares, spread across 87 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 0.00% of DBVT.
The largest institutional holders are MPM Bioimpact LLC (5.83%), Siren, L.L.C. (2.95%) and Vivo Capital, LLC (2.93%). Together, the top 10 institutions control 25.4% of shares outstanding. In their latest filings, 5 of the top 10 institutions increased their DBVT positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of DBVT
| Institution | Shares | % Held | Change |
|---|---|---|---|
| MPM Bioimpact LLC | 3.67M | 5.83% | -29.7% |
| Siren, L.L.C. | 1.86M | 2.95% | 0.0% |
| Vivo Capital, LLC | 1.84M | 2.93% | -30.8% |
| Perceptive Advisors Llc | 1.65M | 2.63% | +71.4% |
| Baker Bros. Advisors, LP | 1.46M | 2.32% | 0.0% |
| Artisan Partners Limited Partnership | 1.37M | 2.18% | -38.1% |
| UBS Group AG | 1.31M | 2.09% | +1551.4% |
| Morgan Stanley | 954.91K | 1.52% | +553.5% |
| Logos Global Management LP | 915.00K | 1.46% | +100.0% |
| Patient Square Capital LP | 909.47K | 1.45% | +31.1% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of DBVT
| Fund | Shares | % Held |
|---|---|---|
| Artisan Partners Funds Inc.-Artisan International Small-Mid Fund | 840.25K | 1.34% |
| Fidelity Advisor Series VII-Fidelity Advisor Biotechnology Fund | 428.80K | 0.68% |
| RUSSELL INVESTMENT CO-U.S. Small Cap Equity Fund | 22.71K | 0.04% |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 12.86K | 0.02% |
| RUSSELL INVESTMENT FUNDS-U.S. Small Cap Equity Fund | 5.83K | 0.01% |
| Steward Funds Inc-Steward Values Enhanced International Fund | 4.05K | 0.01% |
| LORD ABBETT SECURITIES TRUST-Lord Abbett Health Care Fund | 2.97K | 0.00% |
| Trust for Professional Managers-ActivePassive International Equity ETF | 2.25K | 0.00% |
| Gabelli Healthcare & WellnessRx Trust | 400 | 0.00% |
Frequently asked questions
Who is the largest shareholder of DBV Technologies S.A.?
MPM Bioimpact LLC is the largest institutional shareholder of DBVT, owning 5.83% of shares outstanding (3.67M shares) as of its latest 13F filing.
What percentage of DBV Technologies S.A. is owned by institutions?
Institutions own about 41.7% of DBVT shares and 41.7% of the public float.
How much of DBV Technologies S.A. do insiders own?
Insiders, such as officers and directors, own about 0.00% of DBVT shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.